Cargando…

Multitracer PET/CT with [(18)F]Fluorodeoxiglucose and [(18)F]Fluorocholine in the Initial Staging of Multiple Myeloma Patients Applying the IMPeTus Criteria: A Pilot Study

Initial staging of patients diagnosed with multiple myeloma (MM) can lead to negative results using conventional diagnostic imaging workup, including [(18)F]Fluorodesoxiglucose ([(18)F]FDG) PET/CT. The aim of this prospective pilot study was to evaluate the diagnostic efficacy of [(18)F]Fluorocholin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garrastachu Zumarán, Puy, García Megías, Irene, Mangas Losada, María, Mendoza Melero, Alejandro, Villanueva Torres, Amós, Boulvard Chollet, Xavier, Romero Robles, Leonardo, Hernández Pérez, Prisma Montserrat, Ramírez Lasanta, Rafael, Delgado Bolton, Roberto C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177931/ https://www.ncbi.nlm.nih.gov/pubmed/37174961 http://dx.doi.org/10.3390/diagnostics13091570

Ejemplares similares

[(18)F]FDG PET/CT in the Evaluation of Melanoma Patients Treated with Immunotherapy
por: Mangas Losada, María, et al.
Publicado: (2023)

The prognostic significance of [(18)F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs)
por: Sachpekidis, Christos, et al.
Publicado: (2021)

[(18)F]-FDG PET/CT in oncologic patients with unsuspected asymptomatic infection with SARS-CoV-2
por: Cabrera Villegas, Antonio, et al.
Publicado: (2020)

The Role of (18)F-FDG PET/CT in Multiple Myeloma Staging according to IMPeTUs: Comparison of the Durie–Salmon Plus and Other Staging Systems
por: Deng, Shengming, et al.
Publicado: (2018)

Troubleshooting for F-18 Fluorocholine Synthesis: An Institutional Experience
por: Vatsa, Rakhee, et al.
Publicado: (2018)

Unusual Uptake of [(131)I] in a Tenosynovial Giant Cell Tumour Relapse in a Patient with Differentiated Thyroid Cancer
por: Sánchez, Francisco Manuel Cañete, et al.
Publicado: (2022)

Sentinel Node Biopsy Imaging in Breast Cancer: Scatter Reduction Using 3-Dimensionally Printed Lead Shields
por: Cañete-Sánchez, Francisco M., et al.
Publicado: (2022)

Dural Metastases of Advanced Prostate Cancer Detected by (18)F-Fluorocholine
por: Morassi, Mauro, et al.
Publicado: (2020)

Detection of an undescended parathyroid adenoma with (18)F-fluorocholine PET/CT
por: Booij, J., et al.
Publicado: (2022)

Preoperative Imaging with [(18)F]-Fluorocholine PET/CT in Primary Hyperparathyroidism
por: Dekorsy, Franziska J., et al.
Publicado: (2022)

Incidental Findings on (18) F-Fluorocholine PET/CT for Parathyroid Imaging
por: Broos, Wouter A.M., et al.
Publicado: (2022)

Thyroid (18)F-fluorocholine uptake in patients with chronic autoimmune thyroiditis
por: Ciappuccini, Renaud, et al.
Publicado: (2022)

High turnover renal osteodystrophy due to secondary hyperparathyroidism diagnosed by (18)F-Fluorocholine combined with (18)F-NaF PET/CT
por: Xiong, Lin, et al.
Publicado: (2021)

Intra-vagal parathyroid adenoma on digital PET/CT with (18)F-fluorocholine
por: Mainta, Ismini C., et al.
Publicado: (2021)

Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2015)

Incidental uptake of (18)F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer
por: Hodolic, Marina, et al.
Publicado: (2014)

Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [(18)F]fluorocholine PET/CT
por: Kwee, Sandi A., et al.
Publicado: (2015)

Optimal scan time for evaluation of parathyroid adenoma with [(18)F]-fluorocholine PET/CT
por: Rep, Sebastijan, et al.
Publicado: (2015)

Detection of Synchronous Parathyroid Adenoma and Breast Cancer with (18)F-Fluorocholine PET-CT
por: Vorselaars, Wessel MCM, et al.
Publicado: (2015)

Diagnostic accuracy of F-18-Fluorocholine PET/CT and multiparametric MRI for prostate cancer
por: Kim, Jung Kwon, et al.
Publicado: (2022)

Erratum to: Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2016)

Differentiation of hepatocellular adenoma and focal nodular hyperplasia using (18)F-fluorocholine PET/CT
por: van den Esschert, Jacomina W., et al.
Publicado: (2010)

Occult Prostate Cancer Detected with 18F-Fluorocholine Positron Emission Tomography/Computed Tomography
por: Xie, Wanying, et al.
Publicado: (2014)

(18)F-Fluorocholine PET and 4D-CT in Patients with Persistent and Recurrent Primary Hyperparathyroidism
por: Latge, Adrien, et al.
Publicado: (2021)

Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [(18)F]DCFPyL-PET: comparison to [(18)F]fluorocholine-PET
por: Yang, Dae-Myoung, et al.
Publicado: (2021)

Feasibility of (18)F-Fluorocholine PET for Evaluating Skeletal Muscle Atrophy in a Starved Rat Model
por: Park, Sun Mi, et al.
Publicado: (2022)

Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging
por: Kwee, Sandi A., et al.
Publicado: (2012)

Impact of fasting on (18)F-fluorocholine gastrointestinal uptake and detection of lymph node metastases in patients with prostate cancer
por: Wondergem, Maurits, et al.
Publicado: (2016)

Visualization of Macroprolactinoma by (18)F-Fluorocholine PET/CT in a Patient With Multiple Endocrine Neoplasia Type 1
por: Paepegaey, Anne-Cécile, et al.
Publicado: (2018)

[(18)F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer
por: Pasqualetti, Francesco, et al.
Publicado: (2019)

Value of 18F-fluorocholine PET/CT in predicting response to radical radiotherapy in patients with localized prostate cancer
por: Sepulcri, Matteo, et al.
Publicado: (2021)

Hyperfunctioning parathyroid gland and skeletal involvement on [(18)F]fluorocholine PET/CT: one look with two views
por: Nappi, Carmela, et al.
Publicado: (2022)

Detection of recurrence sites using (18)F-fluorocholine PET/CT in prostate cancer patients with PSA failure
por: Kim, Dong-Yun, et al.
Publicado: (2023)

Improving mental health literacy among young people aged 11–15 years in Java, Indonesia: the co-development of a culturally-appropriate, user-centred resource (The IMPeTUs Intervention)
por: Brooks, Helen, et al.
Publicado: (2021)

Head-to-head comparison of [(18)F]-fluorodeoxyglucose and [(18)F]-fluorocholine positron emission tomography/computed tomography in three patients with rare gestational trophoblastic neoplasms: A case series
por: Thientunyakit, Tanyaluck, et al.
Publicado: (2019)

[(18)F]fluciclovine vs. [(18)F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients
por: Ferrari, Cristina, et al.
Publicado: (2022)

Incremental role of (18)F-fluorocholine PET/CT over technetium-99m-labeled MIBI scan in hyperparathyroidism
por: Behera, Abhishek, et al.
Publicado: (2016)

The Significance of 18F-Fluorocholine-PET/CT as Localizing Imaging Technique in Patients with Primary Hyperparathyroidism and Negative Conventional Imaging
por: Fischli, Stefan, et al.
Publicado: (2018)

Prognostic Value of (18)F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel
por: Quaquarini, E., et al.
Publicado: (2019)

Quantitative (18)F-fluorocholine positron emission tomography for prostate cancer: correlation between kinetic parameters and Gleason scoring
por: Schaefferkoetter, Joshua D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gu43u931i671jnfme6idf17phq